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Abstract
Objective: To validate the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) 
12-	item	tool	against	the	36-	item	version	for	measuring	functioning	and	disability	asso-
ciated with pregnancy and the occurrence of maternal morbidity.
Methods:	This	is	a	secondary	analysis	of	the	Brazilian	retrospective	cohort	study	on	
long- term repercussions of severe maternal morbidity (SMM) among women who 
delivered	 at	 a	 tertiary	 facility	 (COMMAG	 study).	We	 compared	WHODAS-	12	 and	
WHODAS- 36 scores of women with and without SMM using measures of central ten-
dency	and	variability,	tests	for	instruments’	agreement	(Bland-	Altman	plot),	confirma-
tory	factor	analysis	(CFA),	and	Cronbach	alpha	coefficient	for	internal	consistency.
Results: The COMMAG study enrolled 638 women up to 5 years postpartum. Although 
the	median	WHODAS-	36	and	 -	12	 scores	 for	 all	women	were	 statistically	different	
(13.04	and	11.76,	respectively;	P<0.001),	there	was	a	strong	linear	correlation	between	
them.	Furthermore,	the	mean	difference	and	the	differences	in	variance	analyses	dem-
onstrated agreement of total scores between the two versions. CFA demonstrated 
how	the	WHODAS-	12	questions	are	divided	into	six	previously	defined	factors	and	
Cronbach alpha showed good internal consistency.
Conclusion: WHODAS- 12 demonstrated agreement with WHODAS- 36 for total 
score	and	was	a	good	instrument	for	screening	functioning	and	disability	among	post-
partum women, with and without SMM.
K E Y W O R D S
Cohort	studies;	Disability;	Functionality;	Pregnancy;	Pregnancy	complications;	Severe	maternal	
morbidity;	Validation	studies
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1  | INTRODUCTION
According	to	the	United	Nations	World	Report	on	Disability,	more	than	
1 billion people in the world live with some form of disability, of which 
nearly	200	million	experience	considerable	difficulties	in	functioning.	
Globally,	people	with	disabilities	have	poorer	health	outcomes,	lower	
educational	 achievements,	 less	 economic	 participation,	 and	 higher	
rates	of	poverty	than	people	without	disabilities.1 However, the bur-
den of ill health associated with pregnancy- related and obstetric com-
plications	 is	yet	 to	be	completely	understood	because	of	 the	broad	
impact of short- and long- term consequences.2	Functioning	and	dis-
ability	among	women	of	reproductive	age	is	poorly	studied.	The	use	
of	a	simple	and	effective	tool	to	identify	and	measure	disability	in	the	
postpartum period is key to improving maternal health worldwide.2,3
The	WHO	has	made	efforts	to	address	the	problem	of	identifying	
and	assessing	disability	and	functioning	by	establishing	an	international	
classification	 system,	 the	 International	 Classification	 of	 Functioning,	
Disability and Health (ICF).4 All standard instruments for measuring dis-
ability	and	health	needed	to	be	linked	conceptually	and	operationally	to	
the	ICF	to	allow	comparisons	across	different	cultures	and	populations	
using	these	new	concepts.	Using	the	ICF’s	conceptualization	of	disability,	
WHO developed a new tool—the WHO Disability Assessment Schedule 
(WHODAS)—to	measure	difficulties	 in	performing	daily	activities	 in	a	
more	simplified	manner.	Like	ICF,	the	tool	was	designed	to	“assess	the	
limitations	on	activity	and	restrictions	on	participation	experienced	by	
an	 individual,	 irrespective	of	medical	 diagnosis”.5 The WHODAS tool 
was	refined	to	include	cross-	cultural	measurement	of	health	status	and	
to respond to calls for improving the scope and cultural adaptability 
of the original WHODAS. Its second version (WHODAS 2.0) was pre-
sented	as	a	general	measure	of	functioning	 impairment	and	disability	
in major life domains. The WHODAS 2.0 instrument intends to mea-
sure	activity	function	and	participation	in	daily	activities	in	the	30	days	
preceding	its	application.5,6 The instrument has three versions, two of 
which	were	compared	in	this	analysis.	The	complete	36-	question	ver-
sion (WHODAS- 36) was administered, and the results of the abbrevi-
ated	12-	question	version	(WHODAS-	12)	were	compared	with	those	of	
the	full	version	simply	by	extracting	and	analyzing	the	relevant	subset	of	
12	questions.	The	possibility	of	using	a	shorter	version	of	the	instrument,	
the	WHODAS-	12,	 is	 appealing	 when	 planning	 population	 screening	
surveys; however, WHODAS- 12 has neither been tested nor validated 
among pregnant women. For each domain of the original WHODAS- 36, 
the	12-	item	version	 includes	 two	sentinel	 items	with	good	screening	
properties	that	 identify	over	90%	of	individuals	with	mild	functioning	
impairment,	based	on	all	36	items,	in	general	populations.5
WHODAS 2.0 was translated into, culturally adapted to, and val-
idated for various languages, including Brazilian Portuguese, for a 
study that implemented it among postpartum women with and with-
out severe maternal morbidity (SMM).7,8	 This	 retrospective	 cohort	
study	included	638	women	who	delivered	at	a	tertiary	public	hospital	
in Brazil. Women with SMM showed increased WHODAS- 36 scores 
(functioning	impairment)	compared	with	women	without	SMM.9
The	objectives	of	the	current	analysis	were	to	compare	and	vali-
date the abbreviated WHODAS- 12, using the complete WHODAS- 36 
as the reference, for assessing postpartum disability among women 
(both with and without maternal morbidity) who delivered up to 
5 years before assessment.
2  | MATERIALS AND METHODS
This	is	a	secondary	analysis	of	the	Brazilian	retrospective	cohort	study,	
known as COMMAG, on the long- term repercussions of SMM on 
women	who	delivered	at	a	tertiary	maternity	unit	(between	July	2008	
and June 2012).9 The methods have previously been published.9,10 
Briefly,	WHODAS	2.0	was	 applied	 to	 a	 cohort	 of	women	with	 and	
without	 the	 diagnosis	 of	 SMM	 (potentially	 life-	threatening	 condi-
tions	and	maternal	near-	miss	incidents),	according	to	WHO	standard	
definition	and	criteria.11	Score	calculations	for	the	analysis	used	the	
WHODAS	“item-	response-	theory”	(IRT)	based	scoring.5
After	 obtaining	 individual	 informed	 consent,	 face-	to-	face	 inter-
views were carried out by healthcare professionals specially trained 
for	 the	 study.	All	women	meeting	 the	 SMM	 criteria	who	 delivered	
during	the	study	period	were	invited	to	participate	and	a	control	group	
(1:1	rate)	was	also	selected.	For	each	woman	who	experienced	SMM	
(“exposed”	group),	a	woman	without	SMM	(“nonexposed	group”),	irre-
spective	of	other	less-	severe	morbidities,	and	who	delivered	the	same	
year	and	at	the	same	institution,	was	recruited.
The	full	version	of	WHODAS	2.0	(36	items)	has	six	domains.	The	
first	domain,	“cognition”	(six	questions),	evaluates	communication	and	
thinking	activities,	including	concentration,	memory,	problem	solving,	
learning,	and	communication.	The	second	domain	assesses	“mobility”	
(five	 questions),	 including	 physical	 capabilities	 such	 as	 standing	 up,	
moving around inside the house, going outside the house, and walking 
a	long	distance.	The	third	domain,	“self-	care”	(four	questions),	measures	
an	 individual’s	 capacity	 to	 carry	 out	 needs	 such	 as	 hygiene,	 getting	
dressed,	 eating,	 and	 staying	 alone.	The	 fourth	 domain,	 “relationship	
with	people”	 (five	questions),	examines	 interactions	with	others,	and	
difficulties	 that	 an	 individual	 with	 adverse	 health	 conditions	 may	
encounter.	The	fifth	domain,	on	“life	activities”	(eight	questions),	eval-
uates	difficulty	with	daily	activities	(household	responsibilities,	leisure,	
work,	 and	 school).	The	 last	domain,	 “participation”	 (eight	questions),	
assesses	social	dimensions,	such	as	engaging	in	community	activities,	
barriers	and	obstacles	to	such	interactions,	and	other	problems,	such	
as maintenance of personal dignity.6	Response	options	for	every	ques-
tion	are:	no	difficulty,	little,	moderate,	severe,	and	extreme	difficulty.
To	study	WHODAS-	12,	 the	questions	common	to	WHODAS-	36	
were labelled from S1 to S12 (Table 1) and these comprise two cor-
responding	questions	 from	each	WHODAS-	36	domain	 (sentinel	key	
questions).6 It should be noted that if the woman does not work or 
study,	the	number	of	questions	in	the	versions	reduces	to	11	and	32,	
respectively	 (this	 impacts	 the	analysis	discussion	as	 some	questions	
will have missing values). Both the full and short versions of WHODAS 
2.0 generate an overall score ranging from 0 to 100 (0=no disability; 
100=full disability).
To perform the comparison between WHODAS- 36 and 
WHODAS- 12 scores, we analyzed the overall median, mean, and 
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standard	 deviation.	 Differences	 in	 medians	 were	 tested	 using	 the	
nonparametric	Wilcoxon	 signed	 rank	 test	 because	of	 skewed	distri-
butions.	In	addition	to	the	measures	of	central	tendency,	the	Pearson	
correlation	coefficient	was	used	to	address	linear	correlation	between	
WHODAS-	36	 and	WHODAS-	12	 total	 scores	 through	 the	 different	
dispersion values. Then, to evaluate the mean and variance of the dif-
ference between WHODAS- 12 and WHODAS- 36 scores, we used 
the	Bland-	Altman	plot	with	Pitman	test	of	difference	in	variance.	Both	
methods were used to evaluate agreement between the short and full 
versions of WHODAS 2.0.12,13 These analyses were repeated to com-
pare each domain across the two tools. The score for each domain was 
proportionally	converted	to	a	score	also	ranging	from	0	to	100.
Additionally,	we	compared	 the	5th,	10th,	25th,	50th,	75th,	90th,	
and	95th	percentiles	 (with	their	respective	95%	confidence	intervals)	
of total score for both groups (with and without morbidity), using 
McNemar	test	to	evaluate	statistical	difference	between	WHODAS-	12	
and	WHODAS-	36	 through	 the	different	 cut-	off	points	 for	 each	per-
centile.	A	P	value	of	0.05	or	below	was	considered	statistically	signif-
icant.	Finally,	we	performed	a	confirmatory	 factor	analysis	 (CFA)	and	
Cronbach α	 to	 evaluate	 the	 intercorrelation	 between	WHODAS-	12	
questions	and	domains,	and	to	measure	the	internal	consistency	of	the	
short	instrument,	respectively.	CFA	was	applied	according	to	the	Kaiser-	
Meyer- Olkin (KMO) measure of sampling adequacy, and the method 
used	for	extraction	was	the	Varimax	method	with	Kaiser	Normalization.
The study protocol was assessed and approved by the local 
Institutional	Review	Board	of	 the	School	of	Medical	Sciences	at	 the	
University of Campinas and complied with all ethical requirements 
for studies involving human beings in Brazil. Each woman was fully 
informed and signed an individual consent form before being enrolled. 
Participating	 women	 were	 initially	 approached	 and	 interviewed	 by	
phone using the computer assisted telephone interview (CATI) unit, 
at	which	time	they	were	invited	to	the	hospital	for	a	visit.	During	this	
visit,	additional	evaluations	were	performed,	including	an	assessment	
of the corresponding child.
3  | RESULTS
The COMMAG study enrolled 638 women, 323 without and 315 with 
severe	maternal	morbidity.	Their	general	characteristics	are	published	
elsewhere.9	In	total,	631	women	completed	the	entire	WHODAS-	36	
instrument,	 which	 in	 turn	 contains	 all	 the	WHODAS-	12	 questions.	
Missing	information	in	any	domain	limits	the	calculation	of	the	total	
scores	and	therefore	seven	women	were	excluded	from	the	analysis.	
The results presented compare the 36- item and 12- item scores for all 
631	women	with	complete	data;	 the	differences	between	scores	 in	
women	with	morbidity	or	without	morbidity	are	explained	in	further	
detail elsewhere in this Supplement.14
In comparing the two instruments, the median of WHODAS- 36 
and WHODAS- 12 total scores as well as those for each domain were 
assessed. The values for the total scores for the 631 women were 
13.04 and 11.76 (P<0.001),	respectively	(Table	2).	The	domain	scores	
TABLE  1 WHODAS-	12	and	WHODAS-	36	questions.a
WHODAS- 12 WHODAS- 36
S1 D 2.1
S2 D 5.1
S3 D 1.4
S4 D 6.1
S5 D 6.5
S6 D 1.1
S7 D 2.5
S8 D 3.1
S9 D 3.2
S10 D 4.1
S11 D 4.2
S12 D 5.5
aComplete	and	translated	tools	can	be	accessed	at:	http://www.who.int/
classifications/icf/form_whodas_downloads/en/. TABLE  2 Mean and median scores of the full and short versions of 
the WHODAS 2.0 instrument for each domain and total score (n=638).
Domain Score WHODAS- 36 Score WHODAS- 12 P valuea
Domain 1 <0.001
Mean 21.4 17.5
SD 18.2 19.8
Median 15.0 12.5
Domain 2 <0.001
Mean 13.8 18.0
SD 19.0 23.5
Median 6.3 12.5
Domain 3b <0.001
Mean 5.4 3.9
SD 12.3 13.4
Median 0.0 0.0
Domain 4 0.870
Mean 14.6 14.3
SD 20.2 23.5
Median 8.3 0.0
Domain 5b 0.029
Mean 22.2 23.5
SD 26.9 30.2
Median 10.0 0.0
Domain 6 <0.001
Mean 20.4 23.7
SD 20.7 28.1
Median 12.5 16.7
Total scoreb <0.001
Mean 17.4 16.4
SD 15.6 16.0
Median 13.0 11.8
Abbreviation:	SD,	standard	deviation.
aRelated	samples	Wilcoxon	signed	rank	test.
bMissing	information.
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demonstrate	 that	 only	 domain	 4	 showed	 no	 significant	 differences	
between medians (P=0.870). Although central tendency analyses were 
statistically	different	between	the	two	versions,	Figure	1	shows	a	very	
high	linear	correlation	between	WHODAS-	36	and	WHODAS-	12	total	
scores	(correlation	coefficient	of	0.945)	and	Figure	2	shows	that	the	
differences	in	variance	of	different	scores	were	not	statistically	signifi-
cant (P=0.068).	Thus,	the	symmetrical	distribution	of	the	Bland-	Altman	
plot	 shows	 that	WHODAS-	12	neither	over-	nor	underestimates	 the	
total 36- item version score.
In	general,	there	was	a	high	linear	correlation	between	total	scores	
of	WHODAS-	36	and	WHODAS-	12,	with	correlation	coefficients	rang-
ing from 0.658 (domain 3) to 0.957 (domain 2) (Fig. 3). However, the 
analyses	of	mean	differences	and	difference	 in	variance	by	domains	
were	 different	 from	 those	 observed	 for	 the	 total	 score,	 showing	
significant	variance	between	domain	scores	of	the	two	tool	versions	
(Fig.	4).	The	mean	difference	ranged	from	0.231	(domain	4)	to	−4.259	
(domain 2).
Table	3	shows	percentiles	of	the	WHODAS-	12	and	WHODAS-	36	 
total scores for all women and by history of SMM. The WHODAS- 12 
percentile	scores	were	similar	to	those	of	the	WHODAS-	36	for	the	total	
sample	(all	women	regardless	of	SMM	status)	in	all	percentiles.	Figure	5	
shows	the	percentile	scores	of	the	total	sample,	and	a		breakdown	of	
scores	by	women’s	history	of	SMM	using	a	boxplot.	Although	 there	
was	a	statistically	significant	difference	(P=0.003) when comparing the 
36-	and	12-	item	scores	in	the	25th	percentile	for	women	with	SMM	
and	 the	 50th	 percentile	 for	 women	 without	SMM,	 we	 considered	
these	differences	very	small	and	not	clinically	relevant.
The	 CFA	 with	 six	 factors	 showed	 that	 both	 questions	 from	
domains 1, 2, 3, and 5 are grouped in factors 4, 2, 1, and 3, respec-
tively	 (Table	4).	Questions	 from	domains	4	and	6	were	not	grouped	
with	the	corresponding	question	of	the	same	domain.	These	factors	
could	explain	64.3%	of	variance	in	CFA.	Cronbach	α for the 12 ques-
tions	 (n=297)	and	 for	 the	6	domains	 (n=631)	was	0.840	and	0.794,	
respectively.	 The	 analysis	 for	 the	 11-	item	 version	 (n=631),	 exclud-
ing	question	D55a	 (work/school	 activities)	 showed	 similar	 reliability	
(Cronbach α=0.815).
4  | DISCUSSION
Our	validation	study	indicated	that	WHODAS-	12	is	a	good	substitute	
for	WHODAS-	36.	We	found	a	very	high	correlation	between	the	total	
scores	of	WHODAS-	12	and	WHODAS-	36,	but	relatively	poor	agree-
ment	at	the	sublevel	of	specific	domains.	Reassuringly,	the	agreement	
between	the	versions	did	not	seem	to	vary	significantly	according	to	
different	 levels	 of	 functionality	 (different	 percentile	 values).	 Finally,	
the	 confirmatory	 factor	 analyses	 validated	 the	 internal	 consistency	
and reliability of WHODAS- 12.
The	use	of	WHODAS-	36	 in	631	women	 (315	women	who	expe-
rienced SMM and 323 who did not) (COMMAG study)9 has provided 
us with a great opportunity to assess the abbreviated 12- item version, 
enabling	the	validation	of	a	potentially	reproducible,	manageable,	short,	
and	reliable	instrument	to	assess	women’s	functionality.	The	utilization	
of	 standardized	 instruments	 is	 key	 for	 evaluating	 and	 comparing	 the	
long-	term	consequences	of	SMM	across	studies,	sites,	and	complication	
diagnoses.	This	 complex	 challenge	 is	 essential	 for	 advancing	 the	 pro-
motion	of	maternal	health,	particularly	in	the	context	of	the	Sustainable	
Development Goals, which place emphasis on the whole woman and her 
ability	to	work	and	participate	in	economic	and	social	activities.2,3,9,10,15 
These	efforts	follow	WHO’s	standardization	of	the	concepts	of	and	cri-
teria	for	“maternal	near	miss”	and	“potentially	life-	threatening”	in	2009,11 
which	led	to	calls	for	similar	standardization	efforts	for	less-	severe	mater-
nal	morbidities	and	their	consequences	during	and	after	pregnancy.3,16
The 12- item version of WHODAS 2.0 has a similar structure to 
WHODAS-	36,	 and	 comprises	 two	 questions	 for	 each	 domain,	 one	
with	 low	 and	 the	 other	 with	 high	 complexity	 regarding	 the	 func-
tionality	(domain)	that	 is	being	assessed.5 When applied to a general 
F IGURE  1 Correlation between the full and short version scores 
of the WHODAS 2.0 (n=631).
F IGURE  2 Bland- Altman comparison of the 36- and the 12- 
item versions of the WHODAS 2.0. Limits of agreement (reference 
range	for	difference):	−8.866	to	10.766;	mean	difference:	0.950	(CI,	
0.567–1.334); range: 0.000–71.960; Pitman test of difference in 
variance: r=−0.073,	P=0.068, n=631.
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population,	 the	short	version	has	shown	high	correlation	and	agree-
ment	with	WHODAS-	36,	yet	 it	requires	significantly	 less	time	for	 its	
implementation	(about	5	minutes)—a	clear	potential	advantage	of	the	
shorter version.5	 The	 statistically	 significant	 difference	 between	 the	
median	WHODAS-	12	and	WHODAS-	36	scores	is	to	be	expected	con-
sidering	the	relatively	large	sample	size	of	the	COMMAG	study.	Minor	
differences	are	more	likely	to	be	statistically	significant	in	large	studies,	
although, in this case, it seems clinically irrelevant, given the overall low 
scores	presented	across	the	entire	group	of	631	postpartum	women.
The	fact	that	some	questions	did	not	group	as	expected	in	the	CFA	
may be a result of the development of the WHODAS- 36. Originally, it 
was	meant	to	identify	self-	perception	of	multidimensional	disabilities	
using	the	total	score	or	individual	scores	for	each	of	the	six	domains.6 
Questions	in	domains	4	and	6	were	not	grouped	with	the	same	factor	
in	the	CFA,	as	was	expected	(and	as	we	found)	with	questions	in	the	
other	domains.	Questions	D61a	 and	D65a	were	originally	 part	 of	 a	
different	matrix	of	the	ICF	instrument,	addressing	different	aspects	of	
functionality	such	as	community,	social	and	civic	life	(Question	D61a),	
and	mental	function	(Question	D65a),	which	could	explain	the	differ-
ences	in	the	CFA	grouping	for	these	questions.
According to our analyses, even when considering the WHODAS 
total	 score	 percentiles	 for	 women	 with	 or	 without	 SMM,	 the	
F IGURE  3 Correlation between the full and short version scores for each domain of the WHODAS 2.0 (n=638). Abscissa: Domain of 
WHODAS- 36; Ordinate: Domain of WHODAS- 12; Missing data (number of women) for: a=1, b=6.
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WHODAS- 12 total score seemed to agree with that of the full version. 
Though our analysis focused on comparing the 36- and 12- item scores 
across all women, regardless of morbidity status, the subanalysis was 
undertaken	to	ensure	that	there	would	be	no	differences	regardless	of	
the	broad	range	of	values	presented.	The	only	two	statistically	signifi-
cant	differences	between	WHODAS-	12	and	WHODAS-	36	percentiles	
were	found	in	the	25th	and	50th	percentiles,	for	SMM	and	no	mor-
bidity	groups,	respectively,	with	low	overall	scores,	most	likely	with	no	
clinical	significance.	However,	future	studies	should	address	the	issue	
of	 percentile	 cut-	off	 points	 for	WHODAS	 score	 among	 postpartum	
women	and	its	association	with	impaired	functioning.
Additionally,	the	mean	difference	of	Bland-	Altman	analyses	of	the	
total score demonstrated that the short version may not under- or 
overestimate	 the	 score	generated	by	WHODAS-	36.	 In	contrast,	 the	
scores	 of	 each	WHODAS-	12	 domain	 showed	 good	 correlation	 but	
not agreement with those of WHODAS- 36, as previously described.5,6 
Therefore,	although	the	short	version	might	not	identify	specific	dis-
abilities,	 it	 showed	 equivalent	 performance	 in	 evaluating	 functional	
F IGURE  4 Bland- Altman comparison of the 36- and the 12- item versions for each domain of the WHODAS 2.0 (n=638). Domain 1: Limits 
of	agreement	(reference	range	for	difference):	−16.078	to	23.870;	mean	difference:	3.896	(CI,	3.119–4.672);	range:	0.000–100.000;	Pitman	
test of difference in variance: r=−0.161,	P<0.001 (n=638). Domain 2:	Limits	of	agreement	(reference	range	for	difference):	−20.932	to	12.414;	
mean	difference:	−4.259	(CI,	−4.907	to	−3.611);	range:	0.000–96.875;	Pitman	test	of	difference	in	variance:	r=−0.547,	P<0.001 (n=638). Domain 
3:	Limits	of	agreement	(reference	range	for	difference):	−11.054	to	13.974;	mean	difference:	1.460	(CI,	0.973–1.947);	range:	0.000–100.000;	
Pitman test of difference in variance: r=−0.168,	P<0.001 (n=637). Domain 4:	Limits	of	agreement	(reference	range	for	difference):	−23.667	
to	24.129;	mean	difference:	0.231	(CI	−0.698	to	1.160);	range:	0.000–100.000;	Pitman	test	of	difference	in	variance:	r=−0.288,	P<0.001 
(n=638). Domain 5:	Limits	of	agreement	(reference	range	for	difference):	−28.995	to	26.392;	mean	difference:	−1.302	(CI,	−2.383	to	−0.220);	
range: 0.000–100.000; Pitman test of difference in variance: r=−0.243,	P<0.001 (n=632). Domain 6: Limits of agreement (reference range for 
difference):	−32.166	to	25.527;	mean	difference:	−3.320	(CI,	−4.441	to	−2.198);	range:	0.000–89.583;	Pitman	test	of	difference	in	variance:	
r=−0.533,	P<0.001 (n=638).
Domain 1 – Cognition  Domain 2 – Mobility 
Domain 3 – Self-care Domain 4 – Relationships with other 
people
Domain 5 – Life activities Domain 6 – Participation 
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impairment in the total WHODAS score, and could be recommended 
for that purpose in future studies.
WHODAS-	12	 is	 a	 short	 version	 of	 a	 more	 refined	 and	 robust	
instrument,	composed	of	selected	questions	from	the	WHODAS-	36,	
thus,	 a	 high	 correlation	 between	 the	 two	 versions	 is	 not	 surpris-
ing. The Bland- Altman analysis is a useful method to address the 
agreement	 between	 the	 versions	 by	 constructing	 limits	 of	 agree-
ment	calculated	using	 the	mean	and	the	standard	deviation	of	 the	
two scores17 and has been used before to validate quality of life and 
functioning	instruments.18,19	A	study	of	correlation,	instead	of	calcu-
lating	the	variance	of	the	average	scores	(study	of	the	differences),	
is	occasionally	performed	 to	address	agreement	between	different	
instruments, but it can be considered a misleading approach for 
this purpose.12
Another study, performed by Üstun et al.,5 compared WHODAS- 12 
with	other	instruments	that	also	assess	functional	impairment—includ-
ing	 FIM	 (Functional	 Independent	Measure),	 LHS	 (London	 Handicap	
Scale),	SF-	12	and	SF-	36	(Short	Form	Health	Surveys),	and	WHOQOL	
(WHO	 Quality	 of	 Life)—and	 showed	 that	 the	 12-	item	 version	 of	
WHODAS	2.0	has	good	concurrent	validity	 for	general	populations.	
Additionally,	when	comparing	the	values	for	the	total	scores	on	the	36-	
item version (13.04) and 12- item version (11.76) for the 631 women, 
these	scores	place	the	COMMAG	study	population	above	the	72nd	
population	percentile	of	the	general	adult	population.5	These	findings	
suggest	 there	may	 be	 an	 effect	 of	 pregnancy	 on	 functioning	 in	 the	
postpartum	period,	though	more	research	is	necessary	to	confirm	this.
Although the COMMAG study included a large number of women, 
there	 are	 some	 limitations	 regarding	 the	 methods	 and	 findings.	 The	
interval	 between	 pregnancy	 and	 the	 evaluation	 of	 functioning	 using	
TABLE  3 Score	values	of	different	percentiles	of	the	full	and	short	
versions of the WHODAS 2.0 instrument for women with severe 
maternal morbidity (n=311) and women without morbidity (n=320).
Percentile and 
groups
WHODAS- 36 WHODAS- 12
P valueaScore (95% CI) Score (95% CI)
Percentile	5
No morbidity 0.9 (0.0–1.1) 0.0 (0.0–0.0)
SMM 0.0 (0.0–0.9) 0.0 (0.0–0.0)
Total 0.0 (0.0–0.9) 0.0 (0.0–0.0)
Percentile	10
No morbidity 1.9 (1.1–1.9) 0.0 (0.0–0.0)
SMM 1.0 (0.0–2.0) 0.0 (0.0–0.0)
Total 1.1 (0.9–1.9) 0.0 (0.0–0.0)
Percentile	25
No morbidity 4.4 (3.3–5.4) 2.9 (2.8–5.6) 0.701
SMM 5.4 (3.8–7.1) 2.9 (2.8–5.6) 0.003
Total 4.7 (3.8–5.4) 2.9 (2.8–5.6) 0.243
Percentile	50
No morbidity 12.0 (9.4–13.0) 8.8 (8.3–11.8)b 0.014
SMM 15.1 (13.0–17.1) 14.7 (11.8–17.7)b 0.572
Total 13.0 (12.0–14.2) 11.8 (11.1–13.9) 0.082
Percentile	75
No morbidity 23.9 (20.7–27.3) 22.2 (19.4–25.0) 0.839
SMM 30.2 (26.1–33.0) 27.8 (25.0–32.4) >0.999
Total 26.1 (24.53–29.3) 25.0 (23.5–27.8) 0.451
Percentile	90
No morbidity 36.8 (32.6–42.4) 36.0 (32.4–41.5) >0.999
SMM 44.6 (39.6–48.3) 41.2 (38.2–50.0) 0.227
Total 41.3 (37.0–44.5) 38.2 (36.1–43.3) 0.076
Percentile	95
No morbidity 47.0 (41.6–52.2) 47.2 (41.2–55.6) >0.999
SMM 53.9 (46.7–58.5) 51.1 (47.1–58.3) >0.999
 Total 50.4 (45.7–53.8) 50.0 (46.5–55.6) 0.146
Abbreviations:	SMM,	severe	maternal	morbidity;	CI,	confidence	interval.
aDependent	 samples,	 McNemar	 Test,	 cut-	off	 point:	 each	 percentile;	
	percentiles	5	and	10	were	not	compared.
bP=0.009 (Independent samples Mann- Whitney test).
F IGURE  5 Boxplot	of	total	scores	of	WHODAS-	12	and	
WHODAS- 36 for all women in the COMMAG study (n=631). [Colour 
figure can be viewed at wileyonlinelibrary.com]
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WHODAS	2.0	ranged	from	1	to	5	years.	The	different	intervals	of	assess-
ment	may	have	biased	 the	demonstration	of	 an	 association	between	
the	 occurrence	 of	 SMM	 and	 disabilities,	 although	 previous	 analyses	
did not show such impact.9	Additionally,	 although	WHODAS-	36	 and	
WHODAS-	12	are	shown	to	be	valuable	in	assessing	functional	impair-
ment	and	disability	in	women	who	experienced	uncomplicated	pregnan-
cies	or	SMM,	there	is	still	no	clear	cut-	off	point	to	discriminate	between	
women	with	or	without	disability.	A	recent	systematic	review	of	the	con-
sequences	of	maternal	morbidity	on	health-	related	 functioning	 found	
more	than	130	articles	published	between	2005	and	2014	meeting	the	
inclusion	criteria.	However,	the	review	concluded	that	the	evaluation	of	
functioning	domains	was	generally	poor,	highlighting	the	importance	of	
developing	a	specific	instrument	for	pregnant	and	postpartum	women.20
Additional	secondary	analyses	and	further	studies	aiming	to	val-
idate	 a	 reliable	 cut-	off	 for	 this	 population	 would	 be	 valuable.	 The	
recent	recognition	of	the	importance	and	advances	in	the	conceptu-
alization	of	maternal	morbidity	for	maternal	health	care	highlights	the	
need	for	surveillance	of	the	repercussions	of	maternal	complications.	
Future	studies	need	to	address	the	identification	of	domains	specific	
to women during pregnancy and the postpartum period (including 
important	functioning	for	the	pregnant	or	postpartum	circumstances,	
e.g.	ability	to	breastfeed,	care,	and	response	to	the	needs	of	newborns)	
that could be added to the instrument. This in turn would clarify the 
burden	of	pregnancy	itself	and	SMM,	enabling	early	identification	of	
adverse	outcomes	and	the	 implementation	of	 intervention	packages	
and strategies to prevent and treat them.2,3,21
The total scores derived from the short version of WHODAS 
showed good agreement with scores on the 36- item version, and 
it was found to be a good instrument for screening women with 
pregnancy-	associated	 functional	 impairment	 and	 disability.	 The	 use	
of a simple, short, and reproducible tool to measure disability in the 
postpartum period is crucial to improving maternal health worldwide, 
especially considering the adverse repercussions of severe maternal 
morbidity.	A	cut-	off	for	both	versions	would	be	a	step	forward	in	eval-
uating	 functionality	 and	 remains	 a	 great	 challenge	 to	be	 addressed.	
Future	 research	 focusing	 on	 functional	 impairment	 may	 improve	
maternal health and enable awareness of issues not frequently consid-
ered during postpartum care.
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D14a Learning a new task 0.025 0.118 0.144 0.458 0.125 0.037
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